We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Biopharma Credit Plc | LSE:BPCR | London | Ordinary Share | GB00BDGKMY29 | ORD USD0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.876 | 0.876 | 0.878 | 283,219 | 09:03:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 135.74M | 108.45M | 0.0833 | 10.56 | 1.15B |
TIDMBPCR
RNS Number : 0722E
BioPharma Credit PLC
03 May 2017
BIOPHARMA CREDIT PLC
CORRECTION: FINAL RESULTS OF ISSUE
The Company announces that certain details contained within the "Final Results of Issue" announcement released on 23 March 2017 at 7:02 under RNS No 2921A require amendment following final determination of the relevant figures as follows:
-- The PL Associates hold 106,139,245 Shares accounting for proceeds of US$106,139,245 or c.13.93% of the Gross Issue Proceeds and not 106,209,484 Shares accounting for proceeds of US$106,209,484 or c.13.94% of the Gross Issue Proceeds.
-- Mr. Pablo Legorreta acquired 3,268,808 Shares through the BioPharma III Interest and not 3,325,000 Shares.
-- Mr. Pedro Gonzalez de Cosio acquired 163,441 Shares through the BioPharma III Interest and not 166,250 Shares.
-- Mrs. Almudena Legorreta acquired 653,762 Shares through the BioPharma III Interest and not 665,000 Shares.
-- 26,679,844 Shares were issued to members of the PL Associates on Initial Admission pursuant to the PL Subscription and the BioPharma III Tender Offer and not 26,750,083 Shares.
-- The reference to the potential increase in the PL Associates shareholding following a repurchase by the Company of its own Shares should be to 16.39% and not 16.40%.
All other details remain unchanged. Terms not otherwise defined herein have the meaning given to them in the "Final Results of Issue" announcement released on 23 March 2017 at 7:02 under RNS No 2921A.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFIFEIIVIID
(END) Dow Jones Newswires
May 03, 2017 09:05 ET (13:05 GMT)
1 Year Biopharma Credit Chart |
1 Month Biopharma Credit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions